Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Tolerability in Elderly”

538 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 538 results

Large-scale testing (Phase 3)Study completedNCT01302860
What this trial is testing

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 17
Early research (Phase 1)Study completedNCT00751413
What this trial is testing

Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)

Who this might be right for
Asthma
Merck Sharp & Dohme LLC 22
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Testing effectiveness (Phase 2)Study completedNCT06754384
What this trial is testing

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Who this might be right for
Hand, Foot, and Mouth Disease (HFMD)Herpangina
Sinovac Biotech Co., Ltd 552
Testing effectiveness (Phase 2)UnknownNCT04536454
What this trial is testing

Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside)

Who this might be right for
Cancer
University Hospital Tuebingen 32
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Early research (Phase 1)Study completedNCT04961359
What this trial is testing

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Testing effectiveness (Phase 2)Study completedNCT00984516
What this trial is testing

Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

Who this might be right for
CicatrixWound-healing
Renovo 102
Testing effectiveness (Phase 2)Study completedNCT06151288
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 1,015
Large-scale testing (Phase 3)Study completedNCT00085748
What this trial is testing

Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 114
Early research (Phase 1)Study completedNCT04450004
What this trial is testing

Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.

Who this might be right for
SARS-CoV 2
Medicago 180
Early research (Phase 1)Ended earlyNCT07086664
What this trial is testing

Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

Who this might be right for
Healthy Volunteers
Pfizer 7
Large-scale testing (Phase 3)Study completedNCT00963235
What this trial is testing

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

Who this might be right for
HIV InfectionsPneumococcal Infections
Pfizer 331
Testing effectiveness (Phase 2)Study completedNCT00479648
What this trial is testing

Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants

Who this might be right for
Influenza
Seqirus 612
Large-scale testing (Phase 3)Study completedNCT00560950
What this trial is testing

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Who this might be right for
Pneumococcal Infection
Merck Sharp & Dohme LLC 143
Early research (Phase 1)Study completedNCT02415790
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 112
Early research (Phase 1)Looking for participantsNCT06054893
What this trial is testing

Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

Who this might be right for
Friedreich Ataxia
Biogen 35
Testing effectiveness (Phase 2)Study completedNCT05363293
What this trial is testing

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

Who this might be right for
Alzheimer's DiseaseHealthy Non-elderly and Elderly Adults
Alzamend Neuro, Inc. 65
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Load More Results